GlassScriptPhysician profile
Diana Addis
NPI 1235241597
$526.98
in general payments reported to CMS, 2019-2025
9 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $30.00 · 2021: $45.00 · 2022: $157 · 2023: $24.33 · 2024: $21.71 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $190.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $153.86 | 2022-2024 | Myrisk |
| Dilon Technologies, INC. | $113.14 | 2025 | Hemoblast Bellows |
| Seagen INC. | $60.00 | 2020-2021 | |
| Lilly USA, LLC | $50.82 | 2019-2020 | |
| Mentor Worldwide LLC | $48.77 | 2022-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Koya Medical, INC. | $31.16 | 2025 | Dayspring, Koya Medical |
| Eisai INC. | $29.92 | 2019 | |
| Merck Sharp & Dohme LLC | $26.37 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Addis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.